Evidence map›Paper›PMID 39618672›Full record

ReviewCureus2024

Inflammation in Elite Athletes: A Review of Novel Factors, the Role of Microbiome, and Treatments for Performance Longevity.

Elliot Dinetz, Nataliya Bocharova

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elliot DinetzIntegrative Medicine/Functional Medicine, University of Miami Miller School of Medicine, Miami, USA.
Nataliya BocharovaInternal Medicine, Pikeville Medical Center, Kentucky, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammation is a prevalent issue among athletes, especially those engaged in high-intensity sports, and can reduce the athlete's long-term potential. Over time, chronic inflammation impedes recovery, performance, and ultimately competitiveness, which is evident among some athletes over others. This article explores more novel concepts contributing to inflammation such as the microbiome and genetic predispositions, which are often overlooked in mainstream management, thereby allowing for more personalized therapies for athletes. Additionally, it introduces ways to address inflammation early to help prolong performance longevity and reduce the risk of serious injury holistically for the overall well-being of professional athletes.

Indexed as

athlete longevityathletic performancechronic inflammationchronic injuryholistic approachesinjury preventionmicrobiome and sportsports injury prevention

Identifiers

PMID39618672
PMCPMC11606592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.